JG
RVMD icon

Joel Greenblatt’s Revolution Medicines RVMD Stock Holding History

Joel Greenblatt’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Sell
120,702
-5,199
-4% -$759K 0.05% 520
2026
Q1 		$12.2M Buy
125,901
+12,072
+11% +$1.22M 0.04% 631
2025
Q4 		$9.07M Buy
113,829
+14,715
+15% +$965K 0.03% 665
2025
Q3 		$4.63M Buy
+99,114
New +$3.88M 0.02% 802

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Joel Greenblatt's RVMD Position: Q2 2026 in Review

Joel Greenblatt reduced its Revolution Medicines (RVMD) stake by 4.1% in Q2 2026, selling an estimated $759K and leaving 120,702 shares worth $22.6M. The position accounts for 0.05% of the portfolio, ranked #520.

Joel Greenblatt first reported a position in RVMD in Q3 2025 and has held it in 4 quarters since. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Joel Greenblatt held 120,702 shares of Revolution Medicines worth $22.6M as of Q2 2026.
  • Joel Greenblatt sold 5,199 Revolution Medicines shares in Q2 2026, an estimated $759K.
  • Revolution Medicines made up 0.05% of Joel Greenblatt's portfolio in Q2 2026, its #520 holding.
  • Joel Greenblatt first reported a position in Revolution Medicines in Q3 2025 and has held it in 4 quarters since.
  • 688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.